Cita APA

Bernabé-Caro, R., Garrido, P., García Campelo, R., Palmero, R., Artal, Á., Bayona, C., & Castro, J. d. (2022). Alectinib after failure to crizotinib in patients with ALK-positive non-small cell lung cancer: Results from the Spanish early access program.

Citación estilo Chicago

Bernabé-Caro, Reyes, Pilar Garrido, Rosario García Campelo, Ramón Palmero, Ángel Artal, Cristina Bayona, y Javier de Castro. Alectinib After Failure to Crizotinib in Patients With ALK-positive Non-small Cell Lung Cancer: Results From the Spanish Early Access Program. 2022.

Cita MLA

Bernabé-Caro, Reyes, et al. Alectinib After Failure to Crizotinib in Patients With ALK-positive Non-small Cell Lung Cancer: Results From the Spanish Early Access Program. 2022.